Treatment with equecabtagene autoleucel, known for short as eque-cel — Iaso Biotherapeutics‘ CAR T-cell therapy candidate for people with progressive forms of multiple sclerosis (MS) — was well tolerated and […]
The post ECTRIMS 2025: Eque-cel shown to ease disability in progressive MS appeared first on Multiple Sclerosis News Today.
Source: multiplesclerosisnewstoday.com